Earlier this year, Palm Beach Pathology (PBP) and Eastern Carolina Pathology (ECP) expanded capacity to perform Covid-19 testing. Our laboratories perform testing for the identification of the SARS-CoV-2 virus via PCR on four different platforms. This gives us the ability to always have available capacity and consistently maintain our leading turnaround times of less than 12 hours from the receipt of a specimen, even in periods of high demand.
Unlike other labs that were formed to perform just Covid-19 testing, PBP and ECP have been performing PCR and other NAA (nucleic acid amplification) molecular testing for 15 years, and were one of the first labs in the U.S. to launch Covid-19 testing in any significant scale. In addition to testing for SARS-CoV-2, the virus that causes Covid-19, we also test for over 80 different viral, bacterial, fungal and parasitic infections across a diverse range of specimen types.
PBP and ECP have now very substantial dedicated capacity for Covid-19 PCR testing that is always available, and are ready to respond instantly when another wave of SARS-CoV-2 infections materializes.